ArticleScientific reports2025
Diagnostic efficiency of chest CT for opportunistic screening for osteoporosis and low BMD in postmenopausal women.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Vertebral trabecular attenuation serial changes on chest CT after autologous hematopoietic stem cell transplantation.Skeletal radiology · 2026Article
- Three-Dimensional Analysis of Facial Skeleton Textures in CBCT as an Early Warning Sign of Osteoporosis-A Pilot Study.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early diagnosis and treatment of osteoporosis and low bone mineral density (BMD) may help avoiding vertebral or other fractures and improving the outcomes. While computed tomography (CT) scans are beneficial for diagnosis, the optimal and most convenient method for opportunistic screening is not yet determined. This retrospective study evaluated how well chest CT can diagnose osteoporosis and low BMD at the T11 and T12 levels, using dual-energy X-ray absorptiometry (DXA) as the standard reference in participants who received CT and DXA scans. We included 147 postmenopausal women. Based on the lowest T-score from the DXA test, all patients were classified into normal, osteopenia, and osteoporosis groups. Both T11 HU and T12 HU showed a strong correlation with T-scores (P < 0.01). They are similar in their ability to diagnose osteoporosis (AUC, 0.806 vs. 0.841; P = 0.210) and low BMD (AUC, 0.824 vs. 0.825; P = 0.977), which may serve as a readily accessible screening tool for early diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.